This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
About Wellington Partners Wellington Partners is a leading European venture capital firm investing in the most promising early- and growth stage life science companies in the fields of biotechnology, therapeutics, medicaltechnology, diagnostics and digital health. With funds totaling more than €1.2 Forbion manages well over EUR 2.3
Inna: Our aim is to improve patient and clinician access to modern, innovative and reliable medicaltechnology. The pipeline for new antibiotics is limited, which is partly due to how new drugdevelopment is funded. We ensure that everything we do has the patient at the heart.
Recent Examples of VC Investment in Wound Care: Corryn Biotechnologies: This UK-based startup raised £550,000 in seed funding to develop a novel wound dressing technology. Clinical Trials: Conducting clinical trials to demonstrate the safety and efficacy of new wound care products and technologies can be expensive and time-consuming.
Virtual Reality (VR) & Augmented Reality (AR): Company: AppliedVR (EaseVRx) - This VR platform uses immersive experiences to distract users from pain and promote relaxation, reducing reliance on medication. Opioid crisis: The public's negative perception of opioids has made investors cautious about pain medications, even non-opioids.
Future releases of Dynamyx will also create opportunities for Fujifilm to support pharmaceutical and contract research organizations with toxicity testing data management for drugdevelopment. “A The company operates as the strategic headquarters for the region.
This collaboration will drive innovations such as faster drugdevelopment and coordinated patient care. With rising medical costs, public cloud platforms will offer cost-efficient solutions for scaling healthcare services, particularly as demand for telemedicine and digital health grows.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content